AstraZeneca Beefs Up in Metabolic Disease, Paying $1.2B to Partner on CSPC Obesity & Diabetes Meds
AstraZeneca is increasing its prospects in cardiometabolic illness, paying $1.2 billion to start a partnership on eight applications that embrace ...
Tag: meds
With CMS’s New List of Meds for Drug Price Negotiation, Analyst Sees Small Financial Hit to Pharmas
Whereas the 15 drugs chosen for the most recent spherical of the federal authorities’s drug value negotiation program will face ...
FDA Adds 6 More Meds to Pilot Program for Speedy Review of Drugs in the National Interest
Two obesity drugs are among the six new medications that could get faster FDA review under a new pilot program ...
Chiesi’s Rare Disease Strategy Expands to Genetic Meds via Alliance With CRISPR Startup Arbor
In the five years since Italy-based Chiesi Group established its rare disease division in Boston, the unit has landed regulatory ...
With FDA Nod in Rare Hormone Disease, Crinetics Can Challenge Blockbuster Meds From Novartis, Ipsen
Drugs for the rare hormone disorder acromegaly include older engineered peptides administered as frequent injections. A new FDA approval brings ...
Which GLP-1 meds have the most side effects? Study of 60,000 Facebook posts gives answers
A deep dive into public Facebook posts uncovers the real-world side effect patterns of GLP-1 medications, revealing what users actually ...
FDA Approves Regeneron Multiple Myeloma Drug With Dosing Edge Over J&J and Pfizer Meds
Regeneron Pharmaceuticals is expanding its cancer drug lineup with FDA approval of a bispecific antibody it developed for multiple myeloma, ...
No link between ADHD meds and psychosis, study says
ADHD stimulant meds don't increase children's risk of psychosis, a new study says. Analysis of stimulant prescriptions among nearly 8,400 ...
Doctors Pushed HIV Meds On Patients in Exchange For Lavish Meals, Trips, and Cash: Prosecutors
A pharmaceutical company that allegedly paid doctors kickbacks to push their HIV/AIDS drugs has agreed to pay a fine of ...
PepGen Drug Shows Signs of Topping Rivals in Rare Muscle Disease With No Approved Meds
A PepGen drug in development for myotonic dystrophy type 1 (DM1) has encouraging early human data that suggest it could ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!